Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 27;11(7):ofae363.
doi: 10.1093/ofid/ofae363. eCollection 2024 Jul.

Clinical Mycology Today: Emerging Challenges and Opportunities

Jessica Little  1   2 , Adriana M Rauseo  3 , Julio C Zuniga-Moya  3 , Andrej Spec  3 , Peter Pappas  4 , John Perfect  5 , Todd McCarthy  4 , Ilan S Schwartz  5
Affiliations
Review

Clinical Mycology Today: Emerging Challenges and Opportunities

Jessica Little et al. Open Forum Infect Dis. .

Abstract

The Mycoses Study Group Education and Research Consortium is a collective of clinicians, researchers, and educators with the common goal to advance awareness, diagnosis, and management of invasive fungal diseases. Clinical Mycology Today, the Mycoses Study Group Education and Research Consortium's biennial meeting, is dedicated to discussing the most pressing contemporary issues facing the field of clinical mycology, promoting clinical, translational, and basic science collaborations, and mentoring the next generation of clinical mycologists. Here, we review the current opportunities and challenges facing the field of mycology that arose from discussions at the 2022 meeting, with emphasis on novel host risk factors, emerging resistant fungal pathogens, the evolving antifungal pipeline, and critical issues affecting the advancement of mycology research.

Keywords: AMR; antifungals; clinical trials; diagnostics; fungal infection; mycoses; mycosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Interplay of risks of fungal disease from novel therapies, traditional inherited or acquired host factors, and genetic risk factors.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. World Health Organization . WHO fungal priority pathogens list to guide research, development and public health action. Geneva: World Health Organization, 2022. Licence: CC BY-NC-SA 3.0 IGO vol. 1.
    1. Neofytos D, Lu K, Hatfield-Seung A, et al. Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy. Diagn Microbiol Infect Dis 2013; 75:144–9. - PMC - PubMed
    1. Shoham S. Emerging fungal infections in solid organ transplant recipients. Infect Dis Clin North Am 2013; 27:305–16. - PMC - PubMed
    1. Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the transplant-associated infection surveillance network (TRANSNET) database. Clin Infect Dis 2010; 50:1091–100. - PubMed
    1. Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol 2011; 49:S7–12. - PubMed